Acorai, a Swedish medical device start-up, begins global clinical trial with first patient enrolled in London. Their breakthrough heart monitor aims for FDA and CE-marking approval in 2024, offering improved heart failure management for 64
Zedsen is renowned for its non-invasive sensing technology applied to early breast cancer detection. With its world class team of scientists and engineers, Zedsen is developing a product to revolutionise the clinical pathway in cancer care.
apoQlar, a pioneering healthtech company, has successfully secured a funding round led by venture capital firm YZR Capital, specializing in health tech investments. This significant investment validates the potential of apoQlar's AR platfor
Berlin Heals Holding AG, a MedTech startup, has developed a breakthrough method and a product for the therapy of heart failure. The product - an electronic device called C-MIC - has already successfully been tested in patients
Tagworks Pharmaceuticals BV ("Tagworks"), the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare
Australia's newest biotech incubator is calling for innovative early-stage Australian biotechs to take up residency in its much-awaited Melbourne-based facility.
Today, Theradaptive, a biopharmaceutical company breaking new ground in targeted regenerative therapeutics, announces that it has closed a $26 million Series A funding round to advance development of its targeted regenerative therapeutics.